Fuzi-lizhong decoction alleviates nonalcoholic fatty liver disease by blocking tlr4/myd88/traf6 signaling

HIGHLIGHTS

  • who: Fuzi-Lizhong Decoction Alleviates Nonalcoholic and colleagues from the Department of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, China Department of Traditional Chinese Medicine, Hubei University of Traditional Chinese Medicine, Wuhan, China have published the paper: Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling, in the Journal: Evidence-Based Complementary and Alternative Medicine of 26/08/2022
  • what: This study aimed to investigate the activities and underlying mechanisms of FLD against disease (NAFLD). In the present study, FLD showed significant effects against NAFLD as evidenced by . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?